NAS:ESLAW (USA)
Â
Warrants (29/09/2028)
$
0.07
0 (0%)
03:23 PM EST
Current and historical daily PE Ratio for Estrella Immunopharma Inc (
) from 2023 to Jun 08 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Estrella Immunopharma stock (ESLAW) PE ratio as of Jun 08 2024 is 0.
More Details
Estrella Immunopharma Inc (ESLAW) PE Ratio (TTM) Chart
Estrella Immunopharma Inc (ESLAW) PE Ratio (TTM) Historical Data
View and export this data going back to 2023. Start your Free Trial
Total 0
- 1
| Estrella Immunopharma PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
Estrella Immunopharma Inc (ESLAW) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Estrella Immunopharma Inc
NAICS : 541714
SIC : 2834
ISIN : US2975841121
Share Class Description:
ESLAW: Warrants (29/09/2028)Description
Estrella Immunopharma Inc is a preclinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors. Estrella's mission is to harness the evolutionary power of the human immune system to transform the lives of patients fighting cancer.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers